For the FDA, non-animal testing methods are the path forward

Published July 5, 2024 2:22pm ET



When we imagine the process of developing new drugs, we often picture scientists working with cutting-edge technology in gleaming laboratories. But there’s a side of pharmaceutical research that is darker, hasn’t changed in decades, and escapes most people’s notice: the widespread and often painful testing conducted on animals.

We recently got a glimpse of that industry when Inotiv, one of the biggest animal testing companies in the United States, received the largest fine in history for violating the Animal Welfare Act, $11 million, for its cruel and neglectful treatment of thousands of beagles being bred for use in laboratories.   

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.